quinoxalines has been researched along with phenylpropanolamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flavahan, NA | 1 |
Adeoya-Osiguwa, SA; Fraser, LR | 1 |
2 other study(ies) available for quinoxalines and phenylpropanolamine
Article | Year |
---|---|
Phenylpropanolamine constricts mouse and human blood vessels by preferentially activating alpha2-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Endothelium, Vascular; Humans; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Phenylpropanolamine; Quinoxalines; Regional Blood Flow; Skin; Tail; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2005 |
Cathine, an amphetamine-related compound, acts on mammalian spermatozoa via beta1- and alpha2A-adrenergic receptors in a capacitation state-dependent manner.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Benzazepines; Brimonidine Tartrate; Calcium; Cyclic AMP; Imidazoles; Male; Mice; Norepinephrine; Phenylpropanolamine; Phosphorylation; Procaterol; Propanolamines; Quinoxalines; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta-1; Sperm Capacitation; Spermatozoa; Tyrosine | 2007 |